I am now retired, holding the positions of Distinguished University Professor Emeritus of Health Science and Policy and Dean Emeritus of the School of Public Health at the University of Pittsburgh. I am the longest serving Dean (2006-2019) in the history of the school. I also served as the inaugural Jonas Salk Chair in Global Health, Director of the Center for Vaccine Research and Associate Vice Chancellor for Global Health.
Prior to becoming Dean at Pittsburgh, I was at the Johns Hopkins Bloomberg School of Public Health, where I was Professor of International Health, Director of the Center for Immunization Research, and won the Golden Apple award for best teacher. Before Johns Hopkins, I served for 23 years on active duty at the Walter Reed Army Institute of Research, where I directed medical research on virus diseases of military importance, including dengue, encephalitis, hepatitis, influenza, and HIV. I lived in Thailand for six years, worked extensively in Cameroon, and led cooperative research in India, China, South Africa, and other counties. I have authored over 300 articles and have a citation index that puts me in the top 1% of all infectious disease experts in the world. Through my studies of patterns of emerging diseases, in 1997 I was the first person in the world to warn that coronaviruses posed a serious threat to human health. While Dean I led an NIH infectious disease modeling Center of Excellence.
I have served in key advisory roles to the WHO, the White House Office of Science and Technology Policy, and the NIH, FDA, and CDC. Most recently I have studied the epidemiology of drug overdoses. I am Past-President of the American Society of Tropical Medicine and Hygiene, a recipient of the John Snow Award for Epidemiology from the American Public Health Association, and the Langmuir Lectureship of the American Epidemiological Society, and I am a Member of the National Academy of Medicine. I co-
founded and served as former president of Epistemix, Inc., a start-up company that produces epidemic modeling software.
Though officially retired, I continue my research collaborations in an advisory role, and work on the history of infectious diseases.
- Bachelor of Arts Degree, Western Reserve University, Cleveland, Ohio, 1967 (chemistry major; honors in biology; magna cum laude; Phi Beta Kappa)
- Doctorate in Medicine, Harvard Medical School, Boston, Massachusetts, 1971
- Clinical Fellow in Medicine (Intern & Junior Resident Physician), Harvard University and the Boston City Hospital, Boston, Massachusetts, 1971-73
- Clinical Fellow in Medicine (Senior Resident Physician), Harvard University and the Massachusetts General Hospital, Boston, Massachusetts, 1975-76
- Research Fellow in Infectious Diseases, Walter Reed Army Medical Center, Washington, DC, 1976-78
- Jalal H, Lee K, Burke DS Oscillating spatiotemporal patterns of COVID-19 in the United States. Sci Rep. 2024 Sep 16;14(1):21562
- Burke DS, Schleunes A. Project MUSE - A Self-Fulfilling Prophecy Pandemic: The 1977 "Russian Flu" Perspect Biol Med. 2024;67(3):386-405
- Castanha PMS, McEnaney PJ, Park Y, Bouwer A, Chaves EJF, Lins RD, Paciaroni NG, Dickson P, Carlson G, Cordeiro MT, Magalhaes T, Craigo J, Marques ETA, Kodadek T, Burke DS. Identification and characterization of a nonbiological small-molecular mimic of a Zika virus conformational neutralizing epitope. Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2312755121.
- Burke DS. Origins of the problematic E in SEIR epidemic models. Infect Dis Model. 2024 Mar 24;9(3):673-679. https://www.sciencedirect.com/science/article/pii/S2468042724000368
- Castanha PMS, Tuttle DJ, Kitsios GD, Jacobs JL, Braga-Neto U, Duespohl M, Rathod S, Marti MM, Wheeler S, Naqvi A, Staines B, Mellors J, Morris A, McVerry BJ, Shah F, Schaefer C, Macatangay BJC, Methe B, Fernandez CA, Barratt-Boyes SM,Burke D, Marques ETA. IgG response to SARS-CoV-2 and seasonal coronaviruses contributes to complement overactivation in severe COVID-19 patients. J Infect Dis. 2022 Mar 10:jiac091. doi: 10.1093/infdis/jiac091.
- Burke DS, Jalal H. Reply commentary by Jalal and Burke.Int J Drug Policy. 2022; 104:103674.doi: 10.1016/j.drugpo.2022.103674
- Jalal H, Burke DS. Exponential growth of drug overdose poisoning and opportunities for intervention. Addiction. 2022;117(5):1200-1202. doi:10.1111/add.15841
- Lee K, Jalal H, Raviotta JM, Krauland MG, Zimmerman RK, Burke DS, Roberts MS. Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States. Open Forum Infect Dis. 2021;9(1):ofab607. doi: 10.1093/ofid/ofab607Yu
- J, Collins ND, Mercado NB, McMahan K, Chandrashekar A, Liu J, Anioke T, Chang A, Giffin VM, Hope DL, Sellers D, Nampanya F, Gardner S, Barrett J, Wan H, Velasco J, Teow E, Cook A, Van Ry A, Pessaint L, Andersen H, Lewis MG, Hofer C, Burke DS, Barkei EK, King HAD, Subra C, Bolton D, Modjarrad K, Michael NL, Barouch DH. Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.J Virol. 2022; 96(2): e0159921. doi: 10.1128/JVI.01599-21.
- Jalal H, Burke DS. Carfentanil and the rise and fall of overdose deaths in the United States. Addiction. 2021;116(6):1593-1599. doi: 10.1111/add.15260.